Back to the Top
Dear Group,
It is well established fact regarding various in vitro blood-brain
barrier drug transport models that down regulation of transport
conditions is a major hurdle. For example: In bovine cultured brain
capillary endothelial cells the expression of glucose transporter
(CGLUT1) is suppressed 150 fold in comparision to the in vivo level. In
conditionally immortalized TR-BBB cells, the transport activity for
3-O-methyl-D-glucose(3-OMG), specific substrate for GLUT1 in these
cells is estimated to be 20 % for that in vivo BBB measured by means of
the Brain uptake Index and/or Brain efflux index methods.
Basing by this fact, is the same problem of downregulation of transport
function carry sense with Caco-2 cell cultures? If so, how it can be
averted. Are there any reports of such a phenomenon in Caco-2 cell
cultures published ??
Regards,
Ravi Kanth
Ravi Kanth Bhamidipati
Research Associate
Dept.of Drug Metabolism and Pharmacokinetics
Discovery Research Division
Dr.Reddy's Laboratories Ltd.
Bollaram Road , Miyapur
Hyderabad - 500 049
Andhra Pradesh
India
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)